The size of the Hemodynamic Monitoring Systems Market worth in Europe was valued at USD 293.11 Million in 2023. It is projected to reach USD 360.58 Million by 2028, growing at a CAGR of 4.23% during the forecast period.
The hemodynamic monitoring system is primarily used for clinical inspection of cardiovascular health, longevity, and quality of life of patients undergoing and recovering from cardiac surgery. Physicians perform hemodynamic monitoring using a pulmonary artery catheter that helps administer and maintain adequate perfusion pressure. It helps to identify these risk factors and improve clinical status.
The growing aging population, rising demand for home-based and non-invasive monitoring systems are majorly driving the European regional market. Y-O-Y growth in cardiac disorders incidence is another factor significantly fuelling the market during the forecast period. As per the statistics published by the European Heart Network, every year, around 3.9 million people are dying through CVDs in Europe. An increasing number of hospitals equipping with hemodynamic monitoring tools is also delivering a healthy boost to the growth rate of the market. Extensive usage of these systems in applications like home healthcare, clinics, hospitals, and ambulatory surgery centers contributes to market growth.
The high costs associated with these devices is one of the prime factors restraining the market. Side effects like bleeding, thrombosis, hemorrhage, and sepsis-related with invasive hemodynamic monitoring is expected to hamper the market growth to a small extent.
This research report on the Europe Hemodynamic Monitoring Systems Market has been segmented and sub-segmented into the following categories:
Based on the region, Europe is the second biggest market globally in terms of market share. Increasing competition and market maturity in this region have reduced the scope of expansion. Numerous awareness programs organized by the European Heart Health Charter is helping the market to thrive further.
The UK market is predicted to lead the European market during the forecast period. The percentage of the aging population diagnosed with various diseases is comparatively high in the United Kingdom than in other European countries.
Germany was accounted for the second-largest share in the European market in 2022. The growing demand for these devices and the ever-increasing number of surgeries happening in this country drive market growth.
Top Companies leading the Europe Hemodynamic Monitoring Systems Market profiled in the report are Edwards Lifesciences Corporation, PULSION Medical Systems SE, LiDCO Group plc., Cheetah Medical Inc., Deltex Medical Group plc., Hemo Sapiens, Inc., ICU Medical, Inc., Osypka Medical GmbH, Schwarzer Cardiotek GmbH, and Tensys Medical, Inc.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com